ERBB2 and breast carcinoma: Here, we performed a retrospective review of concurrent HER2 IHC and HER2 FISH performed at our institution over the past 12 years to determine the frequency of breast carcinomas with discordant results between HER2 IHC and FISH, such as negative HER2 IHC and positive HER2 FISH results.